RxSight (RXST) Total Non-Current Liabilities (2020 - 2025)

RxSight's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $36.1 million for Q4 2025.

• Quarterly Total Non-Current Liabilities rose 1.42% year-over-year to $36.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.1 million (up 1.42% YoY) and the FY2025 annual result came in at $36.1 million, up 1.42% from the prior year.
• Total Non-Current Liabilities was $36.1 million for Q4 2025 at RxSight, up from $32.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $60.3 million in Q4 2022 and bottomed at $19.2 million in Q1 2024.
• A 5-year average of $36.8 million and a median of $33.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities plunged 63.3% — and 2025, when it surged 75.34%.
• RxSight's Total Non-Current Liabilities stood at $54.5 million in 2021, then rose by 10.62% to $60.3 million in 2022, then plunged by 63.3% to $22.1 million in 2023, then surged by 61.1% to $35.6 million in 2024, then rose by 1.42% to $36.1 million in 2025.
• Business Quant data shows RXST's Total Non-Current Liabilities at $36.1 million in Q4 2025, $32.6 million in Q3 2025, and $31.0 million in Q2 2025.